{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:16:32Z","timestamp":1790716592724,"version":"4.1.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.yexcr.2026.115159","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:14:15Z","timestamp":1787930055000},"page":"115159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineered exosomes for CRISPR\/Cas delivery to overcome oncogene-driven drug resistance"],"prefix":"10.1016","volume":"462","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1129-1785","authenticated-orcid":false,"given":"Daniel Ejim","family":"Uti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2026.115159_bib1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/cancers17071082","article-title":"Exploring the genetic orchestra of cancer: the interplay between oncogenes and tumor-suppressor genes","volume":"17","author":"Singh","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2026.115159_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101358","article-title":"Decoding driver and phenotypic genes in cancer: unveiling the essence behind the phenomenon","volume":"103","author":"Liu","year":"2025","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.yexcr.2026.115159_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41392-025-02129-7","article-title":"Molecular principles underlying aggressive cancers","volume":"10","author":"Nussinov","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib4","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.yexcr.2026.115159_bib5","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1158\/0008-5472.CAN-21-3695","article-title":"Understanding drug sensitivity and tackling resistance in cancer","volume":"82","author":"Tyner","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115159_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18010089","article-title":"FGFR aberrations in solid tumors: mechanistic insights and clinical translation of targeted therapies","volume":"18","author":"He","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2026.115159_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s43556-025-00352-w","article-title":"Drug resistance in cancer: molecular mechanisms and emerging treatment strategies","volume":"6","author":"Li","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.yexcr.2026.115159_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41232-025-00398-x","article-title":"Harnessing the potential of gene editing technology for CAR-T cell therapy of solid tumors","volume":"45","author":"Khodabandehloo","year":"2025","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.yexcr.2026.115159_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12943-025-02463-y","article-title":"Advances in RNA-Based cancer therapeutics: pre-clinical and clinical implications","volume":"24","author":"Yan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.115159_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12033-022-00580-3","article-title":"Prime editing: an emerging tool in cancer treatment","volume":"65","author":"Sen","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115159_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13808","article-title":"Prime editing: a revolutionary technology for precise treatment of genetic disorders","volume":"58","author":"Li","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.yexcr.2026.115159_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.yexcr.2026.115159_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444437","article-title":"Advances in delivery systems for CRISPR\/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles","volume":"15","author":"Song","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115159_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115780","article-title":"Technology for nucleic acid delivery in the treatment of hematological malignancies","volume":"230","author":"Abbasi Dezfouli","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yexcr.2026.115159_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s44386-025-00037-y","article-title":"Advancements in RNA-Based therapies from bench to bedside","volume":"3","author":"Singh","year":"2026","journal-title":"Npj Drug Discov"},{"key":"10.1016\/j.yexcr.2026.115159_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70414","article-title":"Design strategies for novel lipid nanoparticle for mRNA vaccine and therapeutics: current understandings and future perspectives","volume":"6","author":"Li","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.yexcr.2026.115159_bib18","article-title":"The evolution of lipid nanoparticles: paving the way for next-generation nucleic acid medicines","volume":"21","author":"Lin","year":"2026","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.yexcr.2026.115159_bib19","article-title":"Tumor-derived exosomes as promising tools for cancer diagnosis and therapy","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115159_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pharmaceutics13010003","article-title":"Exosomes as drug delivery systems: endogenous nanovehicles for treatment of systemic lupus erythematosus","volume":"13","author":"Ortega","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.yexcr.2026.115159_bib21","first-page":"240","article-title":"Engineered exosomes for future gene-editing therapy","volume":"3","author":"Guo","year":"2022","journal-title":"Biomater. Transl."},{"key":"10.1016\/j.yexcr.2026.115159_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7150\/thno.47007","article-title":"Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.yexcr.2026.115159_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/bs.mie.2025.01.001","article-title":"Genome editing with programmable base editors in human cells","volume":"712","author":"Osgood","year":"2025","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.yexcr.2026.115159_bib24","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-Cas9 therapeutics: progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.yexcr.2026.115159_bib25","article-title":"Current insights on the effects of medicinal plants in the management of obesity and infectious diseases: an update from 2020. Asp","author":"Ezichi Favour","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.yexcr.2026.115159_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114087","article-title":"CRISPR\/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells","volume":"181","author":"Bloomer","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yexcr.2026.115159_bib27","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3390\/ijms24065086","article-title":"Role of heterogeneous nuclear ribonucleoproteins in the cancer-immune landscape","volume":"24","author":"Sudhakaran","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115159_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12929-024-01080-z","article-title":"Current landscape of mRNA technologies and delivery systems for new modality therapeutics","volume":"31","author":"Lu","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.yexcr.2026.115159_bib29","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.1038\/s41598-024-58765-6","article-title":"Co-delivery of Cas9 mRNA and guide RNAs for editing of LGMN gene represses breast cancer cell metastasis","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2026.115159_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12985-025-02645-6","article-title":"Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications","volume":"22","author":"Leong","year":"2025","journal-title":"Virol. J."},{"key":"10.1016\/j.yexcr.2026.115159_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","article-title":"Delivery of CRISPR-cas tools for In Vivo genome editing therapy: trends and challenges","volume":"342","author":"Taha","year":"2022","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.yexcr.2026.115159_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040277","article-title":"Prime editing: mechanistic insights and DNA repair modulation","volume":"14","author":"Mentani","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2026.115159_bib33","doi-asserted-by":"crossref","unstructured":"Zhang, W., Petri, K., Ma, J., Lee, H., Tsai, C.-L., Joung, J.K., Yeh, J.-R.J.: Enhancing CRISPR prime editing by reducing misfolded pegRNA interactions. eLife. 12,RP90948. https:\/\/doi.org\/10.7554\/eLife.90948.","DOI":"10.7554\/eLife.90948.2"},{"key":"10.1016\/j.yexcr.2026.115159_bib34","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.ymthe.2026.04.033","article-title":"A primer on prime: a prime editing update from advances to first-in-human trial","volume":"34","author":"Lushington","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib35","article-title":"The improvements and applications of prime editing","volume":"6","author":"Lu","year":"2026","journal-title":"DNA (N. Y.)"},{"key":"10.1016\/j.yexcr.2026.115159_bib36","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41586-025-09537-3","article-title":"Engineered prime editors with minimal genomic errors","volume":"646","author":"Chauhan","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115159_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66737-1","article-title":"Multiplex gene-editing strategy to engineer allogeneic EGFR-Targeting CAR T-cells with improved efficacy against solid tumors","volume":"16","author":"Murray","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115159_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2026.101167","article-title":"A multiplex, prime editing framework for identifying drug resistance variants at scale","author":"Abadie","year":"2026","journal-title":"Cell Genom."},{"key":"10.1016\/j.yexcr.2026.115159_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115159_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102786","article-title":"CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: mechanisms, progress, and challenges","volume":"37","author":"Kantor","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.yexcr.2026.115159_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41434-024-00499-1","article-title":"Prime editing: therapeutic advances and mechanistic insights","volume":"32","author":"Murray","year":"2025","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.618406","article-title":"Base and prime editing technologies for blood disorders","volume":"3","author":"Antoniou","year":"2021","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.yexcr.2026.115159_bib43","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.2147\/IJN.S464249","article-title":"Engineering exosomes for therapeutic applications: decoding biogenesis, content modification, and cargo loading strategies","volume":"19","author":"Bahadorani","year":"2024","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.yexcr.2026.115159_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/JIR.S421649","article-title":"Immune cell-derived exosomes in inflammatory disease and inflammatory tumor microenvironment: a review","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.yexcr.2026.115159_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.647012","article-title":"The role of exosomes derived from mesenchymal stromal cells in dermatology","volume":"9","author":"Qui\u00f1ones-Vico","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2026.115159_bib46","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41419-025-07749-z","article-title":"Tumor exosomal circPTBP3 drives gastric cancer peritoneal metastasis via mesothelial-mesenchymal transition","volume":"16","author":"Dong","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2026.115159_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113751","article-title":"Extracellular-vesicle-packaged S100A11 from osteosarcoma cells mediates lung premetastatic niche formation by recruiting gMDSCs","volume":"43","author":"Deng","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.yexcr.2026.115159_bib48","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41419-022-05472-7","article-title":"Laminins in tumor-derived exosomes upregulated by ETS1 reprogram omental macrophages to promote omental metastasis of ovarian cancer","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2026.115159_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12020384","article-title":"Development of stable packaging and producer cell lines for the production of AAV vectors","volume":"12","author":"Merten","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.yexcr.2026.115159_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102737","article-title":"Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors","volume":"36","author":"Wang","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.yexcr.2026.115159_bib51","article-title":"Cell membrane-derived nanovesicles as extracellular vesicle-mimetics in wound healing","volume":"31","author":"Li","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.yexcr.2026.115159_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.115317","article-title":"Advances in hybrid exosome-liposome nanoparticles for enhanced cancer therapy","volume":"259","author":"Dou","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.yexcr.2026.115159_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110368","article-title":"Advancements in sonication-based extraction techniques for ovarian follicular fluid analysis: implications for infertility diagnostics and assisted reproductive technologies","volume":"26","author":"Chicea","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115159_bib54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12951-025-03528-2","article-title":"Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges","volume":"23","author":"Sanadgol","year":"2025","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.yexcr.2026.115159_bib55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s11671-026-04681-9","article-title":"Exosome-loaded nanoradiosensitizers in radiotherapy for preventing post-irradiation tumor recurrence: mechanisms, preclinical evidence, and translational challenges","volume":"21","author":"Uti","year":"2026","journal-title":"Discov. Nano"},{"key":"10.1016\/j.yexcr.2026.115159_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1687953","article-title":"Smart nanocarriers for cancer: harnessing exosomes and lipid systems in photodynamic and immunotherapy","volume":"16","author":"Swain","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115159_bib57","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3390\/cells10071667","article-title":"Affecting HEK293 cell growth and production performance by modifying the expression of specific genes","volume":"10","author":"Abaandou","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2026.115159_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.796991","article-title":"HEK293 cell line as a platform to produce recombinant proteins and viral vectors","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115159_bib59","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1016\/j.cell.2023.09.006","article-title":"Formation, function, and pathology of RNP granules","volume":"186","author":"Ripin","year":"2023","journal-title":"Cell."},{"key":"10.1016\/j.yexcr.2026.115159_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1019821","article-title":"Extracellular vesicles biogenesis, isolation, manipulation and genetic engineering for potential in vitro and in vivo therapeutics: an overview","volume":"10","author":"Hadizadeh","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115159_bib61","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1021\/acs.chemrev.3c00575","article-title":"RNA: the unsuspected conductor in the orchestra of macromolecular crowding","volume":"124","author":"Zacco","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.yexcr.2026.115159_bib62","doi-asserted-by":"crossref","first-page":"862","DOI":"10.21037\/atm-22-3279","article-title":"CRISPR\/Cas9 ribonucleoprotein (RNP) complex enables higher viability of transfected cells in genome editing of acute myeloid cells","volume":"10","author":"Cheng","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115159_bib76","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.3390\/cells11193171","article-title":"In vitro transfection of Up-Regulated genes identified in favorable-outcome neuroblastoma into cell lines","volume":"11","author":"Hiyama","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2026.115159_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/mps8020023","article-title":"Comparative analysis of methods for assessing On-Target gene editing efficiencies","volume":"8","author":"Yao","year":"2025","journal-title":"Methods Protoc."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115159_bib78","article-title":"Endo-bind-n-seq: identifying RNA motifs of RNA binding proteins isolated from endogenous sources","author":"Hanelt","year":"2024","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.yexcr.2026.115159_bib79","article-title":"N-Terminal sequences of signal peptides assuming critical roles in expression of heterologous proteins in Bacillus subtilis","volume":"12","author":"Zhang","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.yexcr.2026.115159_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101483","article-title":"A method to validate viral copy-number assay involving a hybrid amplicon and duplex droplet digital PCR","volume":"33","author":"Wu","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.yexcr.2026.115159_bib81","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/s41598-020-59790-x","article-title":"The effects of electroporation buffer composition on cell viability and electro-transfection efficiency","volume":"10","author":"Sherba","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2026.115159_bib82","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4103\/bbrj.bbrj_332_25","article-title":"Antibacterial activity of neat and sonicated extracellular vesicles derived from stromal vascular fraction","volume":"9","author":"Srinivasa","year":"2025","journal-title":"Biomed. Biotechnol. Res. J. BBRJ"},{"key":"10.1016\/j.yexcr.2026.115159_bib83","article-title":"Effects of protein sources and extrusion processing conditions via pellet physical quality on the feed intake, gastrointestinal emptying and digestion of spotted seabass (Lateolabrax maculatus)","volume":"37","author":"Xing","year":"2024","journal-title":"Aquac. Rep."},{"key":"10.1016\/j.yexcr.2026.115159_bib84","article-title":"Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9\/AAV6-mediated gene editing in hematopoietic stem cells","volume":"6","author":"Conti","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.yexcr.2026.115159_bib85","doi-asserted-by":"crossref","first-page":"12363","DOI":"10.2147\/IJN.S542641","article-title":"The application of exosomes from different sources loaded with natural small-molecule compounds in disease","volume":"20","author":"Zhang","year":"2025","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.yexcr.2026.115159_bib86","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2020.01.025","article-title":"Click chemistry in proteomic investigations","volume":"180","author":"Parker","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2026.115159_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115461","article-title":"Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids","volume":"215","author":"Bader","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yexcr.2026.115159_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70132","article-title":"Microfluidic devices for manufacture of therapeutic extracellular vesicles: advances and opportunities","volume":"14","author":"Hassanzadeh\u2010Barforoushi","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.yexcr.2026.115159_bib89","article-title":"A pH-responsive PEG coating strategy for enhancing the enrichment of small extracellular vesicles towards disease regions with acidic microenvironment","volume":"32","author":"Zhao","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.yexcr.2026.115159_bib90","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1208\/s12248-021-00560-6","article-title":"Insights on droplet digital PCR\u2013based cellular kinetics and biodistribution assay support for CAR-T cell therapy","volume":"23","author":"Sugimoto","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.yexcr.2026.115159_bib63","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/v15030690","article-title":"Packaging and uncoating of CRISPR\/Cas ribonucleoproteins for efficient gene editing with viral and non-viral extracellular nanoparticles","volume":"15","author":"Mazurov","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.yexcr.2026.115159_bib64","article-title":"Microfluidic nanochips for rapid exosome isolation and multiplex biomarker profiling from a single blood drop: toward sample-to-answer liquid biopsy","volume":"6","author":"Uti","year":"2026","journal-title":"Clin. Transl. Discov."},{"key":"10.1016\/j.yexcr.2026.115159_bib65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/cimb47020091","article-title":"Electroporation induces unexpected alterations in gene expression: a tip for selection of optimal transfection method","volume":"47","author":"Hamada","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.yexcr.2026.115159_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.111","article-title":"CRISPR delivery with extracellular vesicles: promises and challenges","volume":"2","author":"Berggreen","year":"2023","journal-title":"J. Extracell. Biol."},{"key":"10.1016\/j.yexcr.2026.115159_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultsonch.2026.107763","article-title":"Optimization of sonication for preserving the biochemical and physicochemical attributes of pomegranate arils during storage","volume":"126","author":"Hazbawi","year":"2026","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.yexcr.2026.115159_bib68","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41596-024-01113-9","article-title":"Sonication-assisted protein extraction improves proteomic detection of membrane-bound and DNA-Binding proteins from tumor tissues","volume":"20","author":"Li","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yexcr.2026.115159_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1177151","article-title":"Advances in nanomaterial-based targeted drug delivery systems","volume":"11","author":"Cheng","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115159_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1677481","article-title":"Deciphering organotropism reveals therapeutic targets in metastasis","volume":"13","author":"Bautista","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2026.115159_bib71","doi-asserted-by":"crossref","unstructured":"Brodin, B.A., Saladino, G.M., Hertz, H.M., Arsenian-Henriksson, M., Toprak, M.S.: Innate immuno-response to nanoparticle uptake in liver and spleen mimics pathogen infection. Nanomed. 20, 2721\u20132731. https:\/\/doi.org\/10.1080\/17435889.2025.2571024.","DOI":"10.1080\/17435889.2025.2571024"},{"key":"10.1016\/j.yexcr.2026.115159_bib72","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12964-023-01089-1","article-title":"Protein Corona and exosomes: new challenges and prospects","volume":"21","author":"Heidarzadeh","year":"2023","journal-title":"Cell Commun. Signal. CCS."},{"key":"10.1016\/j.yexcr.2026.115159_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10875-025-01965-0","article-title":"Exosomes in autoimmunity: mediators of autoantigen presentation and targets for therapeutic intervention in autoimmune diseases","volume":"46","author":"Almohaimeed","year":"2025","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.yexcr.2026.115159_bib74","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41401-022-00902-w","article-title":"Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy","volume":"43","author":"Mukherjee","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yexcr.2026.115159_bib75","article-title":"A review for uncovering the \u201cProtein-Nanoparticle alliance\u201d: implications of the protein Corona for biomedical applications","volume":"14","author":"Acet","year":"2024","journal-title":"Nanomaterials"},{"key":"10.1016\/j.yexcr.2026.115159_bib91","doi-asserted-by":"crossref","DOI":"10.1177\/11786388251408961","article-title":"Targeting CD44-Hyaluronic acid signalling in obesity treatment: insights from small molecules and nanobioconjugates","volume":"19","author":"Uti","year":"2026","journal-title":"Nutr. Metab. Insights"},{"key":"10.1016\/j.yexcr.2026.115159_bib92","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1186\/s12951-025-03815-y","article-title":"Collagenase-mediated extracellular matrix targeting for enhanced drug penetration and therapeutic efficacy in nanoscale delivery systems for cancer therapy","volume":"23","author":"Gong","year":"2025","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.yexcr.2026.115159_bib93","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","article-title":"The use of alternative strategies for enhanced nanoparticle delivery to solid tumors","volume":"121","author":"Izci","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.yexcr.2026.115159_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1090914","article-title":"Compromised osteogenic effect of exosomes internalized by senescent bone marrow stem cells via endocytoses involving clathrin, macropinocytosis and caveolae","volume":"10","author":"Qi","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115159_bib95","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1039\/D6BM00231E","article-title":"Functional peptide-assisted delivery of CRISPR\/Cas9: recent progress on gene editing","volume":"14","author":"Cho","year":"2026","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.yexcr.2026.115159_bib96","first-page":"96","article-title":"Engineered small extracellular vesicles as bioactive materials: integrating engineering strategies for cargo loading and targeted delivery systems","volume":"59","author":"Xu","year":"2026","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.yexcr.2026.115159_bib97","article-title":"Emerging hallmarks and the rise of complexities and heterogeneity of tumor","volume":"44","author":"Arora","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.yexcr.2026.115159_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11171","article-title":"P-glycoprotein and cancer: what do we currently know?","volume":"8","author":"Pilotto Heming","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.yexcr.2026.115159_bib99","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/cancers12041050","article-title":"DNA damage\/repair management in cancers","volume":"12","author":"Alhmoud","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2026.115159_bib100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib101","first-page":"98","article-title":"Chemoresistance: the hidden barrier in cancer treatment. Cancer pathog","volume":"4","author":"Dhiman","year":"2026","journal-title":"Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib102","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2017.09.013","article-title":"Cancer-derived exosomes as a delivery platform of CRISPR\/Cas9 confer cancer cell tropism-dependent targeting","volume":"266","author":"Kim","year":"2017","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.yexcr.2026.115159_bib103","doi-asserted-by":"crossref","first-page":"16432","DOI":"10.1021\/acsnano.2c12857","article-title":"Engineered extracellular vesicle-delivered CRISPR\/Cas9 for radiotherapy sensitization of glioblastoma","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.yexcr.2026.115159_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70170","article-title":"TMTP1-Modified small extracellular vesicles target BRAF mutation in anaplastic thyroid cancer reversing vemurafenib resistance with CRISPR\/Cas9 delivery","volume":"14","author":"Zhang","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.yexcr.2026.115159_bib105","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000875","article-title":"Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer","volume":"4","author":"McAndrews","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.yexcr.2026.115159_bib106","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2020.07.033","article-title":"Tropism-facilitated delivery of CRISPR\/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies","volume":"326","author":"Xu","year":"2020","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.yexcr.2026.115159_bib107","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1093\/nar\/gkaa683","article-title":"Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR\/Cas9 system for gene therapy","volume":"48","author":"Zhuang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2026.115159_bib108","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.7150\/thno.92703","article-title":"CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis\/TMZ resistance in the mesenchymal subtype of glioblastoma","volume":"14","author":"Zhao","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.yexcr.2026.115159_bib109","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1039\/D0BM00427H","article-title":"An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells","volume":"8","author":"Ye","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.yexcr.2026.115159_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65995-3","article-title":"A modular strategy for extracellular vesicle-mediated CRISPR-Cas9 delivery through aptamer-based loading and UV-activated cargo release","volume":"16","author":"Elsharkasy","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115159_bib111","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/s41467-025-59377-y","article-title":"Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors","volume":"16","author":"Liang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115159_bib112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40164-026-00757-5","article-title":"Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types","volume":"15","author":"Yu","year":"2026","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2026.115159_bib113","first-page":"447","article-title":"Drug-adapted cancer cell lines as preclinical models of acquired resistance","volume":"2","author":"Michaelis","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.yexcr.2026.115159_bib114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-023-01925-5","article-title":"Comprehensive review of CRISPR-Based gene editing: mechanisms, challenges, and applications in cancer therapy","volume":"23","author":"Chehelgerdi","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.115159_bib115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s44385-026-00067-9","article-title":"Accelerating personalized medicine: miniaturized patient-derived organoid drug screening for predicting cancer treatment responses and beyond","volume":"3","author":"Abouleila","year":"2026","journal-title":"Npj Biomed. Innov."},{"key":"10.1016\/j.yexcr.2026.115159_bib116","article-title":"Tumor organoids may be more suitable for clinical personalized chemotherapeutic drug screening in lung adenocarcinoma","volume":"13","author":"Yun","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2026.115159_bib117","first-page":"41","article-title":"Modeling CAF-Tumor interactions to overcome therapy resistance","volume":"45","author":"Gubala","year":"2026","journal-title":"J. Exp. Clin. Cancer Res. CR."},{"key":"10.1016\/j.yexcr.2026.115159_bib118","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41420-025-02407-x","article-title":"Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2026.115159_bib119","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/cells14100732","article-title":"Modeling tumor microenvironment complexity in vitro: spheroids as physiologically relevant tumor models and strategies for their analysis","volume":"14","author":"Shah","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2026.115159_bib120","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/bios12060370","article-title":"Microfluidic Organ-on-a-Chip system for disease modeling and drug development","volume":"12","author":"Li","year":"2022","journal-title":"Biosensors"},{"key":"10.1016\/j.yexcr.2026.115159_bib121","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","article-title":"Patient-derived xenograft (PDX) models, applications and challenges in cancer research","volume":"20","author":"Abdolahi","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115159_bib122","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","article-title":"Patient-derived xenograft models in cancer therapy: technologies and applications","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib123","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ame2.12562","article-title":"Application of humanized mice in the safety experiments of antibody drugs","volume":"8","author":"Sun","year":"2025","journal-title":"Anim. Models Exp. Med."},{"key":"10.1016\/j.yexcr.2026.115159_bib124","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2473163","article-title":"Humanized mouse models of KRAS-Mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies","volume":"14","author":"Davola","year":"2025","journal-title":"OncoImmunology"},{"key":"10.1016\/j.yexcr.2026.115159_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108631","article-title":"Orthotopic and metastatic tumour models in preclinical cancer research","volume":"257","author":"Stribbling","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311582","article-title":"Construction of metastasis prediction models and screening of anti-metastatic drugs based on pan-cancer single-cell EMT features","volume":"26","author":"Xu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115159_bib127","doi-asserted-by":"crossref","unstructured":"Canudo-Barreras, G., Romanos, E., Herrera, R.P., Gimeno, M.C.: ViVo: a temporal modeling framework that boosts statistical power and minimizes animal usage. J. Med. Chem. 69, 1724\u20131734. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c03326.","DOI":"10.1021\/acs.jmedchem.5c03326"},{"key":"10.1016\/j.yexcr.2026.115159_bib128","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/cancers16183186","article-title":"Syngeneic mouse models for pre-clinical evaluation of CAR T cells","volume":"16","author":"Ahmed","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2026.115159_bib129","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1017\/erm.2022.32","article-title":"Precision oncology using ex vivo technology: a step towards individualised cancer care?","volume":"24","author":"Williams","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.yexcr.2026.115159_bib130","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.tibtech.2024.06.007","article-title":"Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance","volume":"42","author":"Yuan","year":"2024","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115159_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104192","article-title":"Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory","volume":"192","author":"Zhang","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.yexcr.2026.115159_bib132","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcancer.2025.12.009","article-title":"Spatial multi-omics in precision medicine: integrating biological insights through multidisciplinary collaboration","volume":"119","author":"Kim","year":"2026","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2026.115159_bib133","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/BTT.S429411","article-title":"Recent advancements in reducing the off-target effect of CRISPR-Cas9 genome editing","volume":"18","author":"Mengstie","year":"2024","journal-title":"Biol. Targets & Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib134","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/nar\/gkac192","article-title":"CRISPR\u2013Cas9 gRNA efficiency prediction: an overview of predictive tools and the role of deep learning","volume":"50","author":"Konstantakos","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2026.115159_bib135","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1093\/plcell\/koad209","article-title":"CRISPR\/Cas9-induced DNA breaks trigger crossover, chromosomal loss, and chromothripsis-like rearrangements","volume":"35","author":"Samach","year":"2023","journal-title":"Plant Cell"},{"key":"10.1016\/j.yexcr.2026.115159_bib136","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: mechanisms, structures and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexcr.2026.115159_bib137","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3390\/life15111729","article-title":"The converging roles of nucleases and helicases in genome maintenance and the aging process","volume":"15","author":"Margariti","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.yexcr.2026.115159_bib138","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jconrel.2024.05.023","article-title":"Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing","volume":"370","author":"Mun","year":"2024","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.yexcr.2026.115159_bib139","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1038\/s41467-022-34045-7","article-title":"Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115159_bib140","doi-asserted-by":"crossref","unstructured":"De Souza Cordeiro, L.M., Atkinson, K.C., Aivazian, A., Joyce, P.F., Jia, F., Mascioni, A.: Electrostatic properties of human germlines and biodistribution of small biologics. mAbs. 16, 2311991. https:\/\/doi.org\/10.1080\/19420862.2024.2311991.","DOI":"10.1080\/19420862.2024.2311991"},{"key":"10.1016\/j.yexcr.2026.115159_bib141","article-title":"Toll-like receptors in health and disease","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.yexcr.2026.115159_bib142","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","article-title":"Immunogenicity of Cas9 protein","volume":"109","author":"Mehta","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.yexcr.2026.115159_bib143","doi-asserted-by":"crossref","first-page":"H1162","DOI":"10.1152\/ajpheart.00075.2020","article-title":"Exosomes in disease and regeneration: biological functions, diagnostics, and beneficial effects","volume":"319","author":"Lin","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2026.115159_bib144","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.2147\/IJN.S548006","article-title":"Extracellular vesicle-based therapeutic cargo delivery for cancer therapy","volume":"20","author":"Huang","year":"2025","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.yexcr.2026.115159_bib145","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12672-026-04748-0","article-title":"Exosomes serve as natural nanocarriers targeting cancer stem cells to advance precision oncology","volume":"17","author":"AlRamadneh","year":"2026","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.yexcr.2026.115159_bib146","first-page":"2226","article-title":"Emerging roles of exosome-derived biomarkers in cancer theranostics: messages from novel protein targets","volume":"12","author":"Cheng","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115159_bib147","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12265-022-10342-w","article-title":"The effect of extracellular vesicles on thrombosis","volume":"16","author":"He","year":"2023","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.yexcr.2026.115159_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.599674","article-title":"Cell-based therapy manufacturing in stirred suspension bioreactor: thoughts for cGMP compliance","volume":"8","author":"Nath","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115159_bib149","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40580-025-00509-x","article-title":"Efficient methods of isolation and purification of extracellular vesicles","volume":"12","author":"Kim","year":"2025","journal-title":"Nano Converg."},{"key":"10.1016\/j.yexcr.2026.115159_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70145","article-title":"GMP\u2010Compliant process for the manufacturing of an extracellular vesicles\u2010enriched secretome product derived from cardiovascular progenitor cells suitable for a phase I clinical trial","volume":"14","author":"Humbert","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.yexcr.2026.115159_bib151","unstructured":"Research, C. for B.E. and: Potency assurance for cellular and gene therapy products, https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/potency-assurance-cellular-and-gene-therapy-products."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:35:11Z","timestamp":1790714111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726002764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":151,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0014482726002764"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115159","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered exosomes for CRISPR\/Cas delivery to overcome oncogene-driven drug resistance","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115159"}}